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Abstract
The study of HutchinsonGilford progeria syndrome (HGPS) has provided important 
clues to decipher mechanisms underlying aging. Progerin, a mutant lamin A, disrupts 
nuclear envelope structure/function, with further impairment of multiple processes 
that culminate in senescence. Here, we demonstrate that the nuclear protein ex-
port pathway is exacerbated in HGPS, due to progerin-driven overexpression of 
CRM1, thereby disturbing nucleocytoplasmic partitioning of CRM1-target proteins. 
Enhanced nuclear export is central in HGPS, since pharmacological inhibition of 
CRM1 alleviates all aging hallmarks analyzed, including senescent cellular morphol-
ogy, lamin B1 downregulation, loss of heterochromatin, nuclear morphology defects, 
and expanded nucleoli. Exogenous overexpression of CRM1 on the other hand re-
capitulates the HGPS cellular phenotype in normal fibroblasts. CRM1 levels/activity 
increases with age in fibroblasts from healthy donors, indicating that altered nuclear 
export is a common hallmark of pathological and physiological aging. Collectively, 
our findings provide novel insights into HGPS pathophysiology, identifying CRM1 as 
potential therapeutic target in HGPS.
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Aging is a universal process that occurs across all living species; in 
humans, aging is characterized by a gradual decline in physical and 
psychological capacities that in turn cause morphological, metabolic, 
and cognitive alterations that limit the quality of life and ultimately 
provoke death. Premature aging syndromes, a group of extremely 
rare but devastating disorders that mimic physiological aging, have 
been proposed as models to decipher the molecular mechanisms un-
7;uѴbm]-]bm]Ő00;mşbv|;ѴbķƑƏƐƕőĺ
HutchinsonGilford progeria syndrome (HGPS), the most well-
studied progeroid syndrome, is typically caused by a silent point mu-
tation (1824C > T) that activates a cryptic splicing site within exon 11 
of the LMNA gene, resulting in the synthesis of a prelamin A mRNA 
that contains an internal deletion of 150 base pairs. Consequently, 
this leads to the translation of a mutant lamin A termed progerin, 
which harbors a deletion of 50 amino acids within its C-terminus. 
Progerin is permanently farnesylated because the deletion elimi-
nates the cleavage site for Zmpste24, the enzyme that removes the 
C-terminal farnesyl group from prelamin A to render mature lamin A 
(Eriksson et al., 2003; De Sandre-Giovannoli et al., 2003).
Progerin acts in a dominant gain-of-function manner by anchor-
ing to the nuclear envelope and perturbing nuclear lamin function, 
thereby inducing a plethora of cellular defects, including aberrant 
nuclear morphology, altered DNA repair and gene expression, and 
|;Ѵol;u; bmv|-0bѴb| Őom-Ѵoķ u;b;mh-lrķ ş vhf-;uķ ƑƏƐƕőĺ $_;
complex network of downstream effects by which progerin exerts 
its toxicity is far from understood; it is thought that progerin impacts 
on central cellular process, which in turn triggers a cascade of nox-
ious downstream effects that ultimately cause aging.
Owing to the deleterious effect exerted by progerin on nuclear 
envelope, we hypothesized that the nucleocytoplasmic transport 
of proteins through the nuclear pore complex (NPC) (Christie et 
al., 2016) could be a primary target of progerin. Supporting our hy-
pothesis, perturbation in the Ran GTPase gradient affecting nuclear 
import of specific proteins, namely Ubc9, and nucleoporin TPR was 
previously reported in HGPS cells (Cobb et al., 2016; Snow, Dar, 
	||-ķ;_Ѵ;m0-1_ķş-v1_-Ѵķ ƑƏƐƒőĺ 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transport pathway mediated by transportin-1 (TNPO1) is impaired 
in HGPS cells, due to cytoplasmic sequestration of TNPO1 by the 
microtubule network (Larrieu et al., 2018).
In this study, we aimed to analyze whether nuclear protein export 
is impaired in HGPS. Exportin-1 (XPO1), also known as chromosomal 
region maintenance 1 (CRM1), binds to cargo proteins through a 
leucine-rich nuclear export signal (NES) and transports the proteins 
across the NPC via a Ran-GTP gradient (Ishizawa, Kojima, Hail, Tabe, 
şm7u;;==ķƑƏƐƔĸbuѴb;|-ѴĺķƑƏƐƔőĺ);v_o=ou|_;=buv||bl;|_-|
the CRM1-driven nuclear protein export mechanism is abnormally 
enhanced in HGPS fibroblasts and that this novel hallmark is critically 
involved in the disease, because pharmacological inhibition of CRM1 
rescues the HGPS cellular phenotype and exogenous overexpression 
of CRM1 recapitulates HGPS in normal fibroblasts.
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is a novel hallmark of HGPS cells
To ascertain whether the CRM1-mediated nuclear protein export 
mechanism is impaired in HGPS, we evaluated the subcellular dis-
tribution of six different proteins whose nuclear export depends 
on NES recognition by CRM1 (STAT3, B23, ZO-2, cyclin B1, Dp71, 
and HDAC1). Two different HGPS fibroblast cultures (HGPS-1 and 
"ŊƑő -m7 - r-vv-];Ŋl-|1_;7 =b0uo0Ѵ-v| 1om|uoѴ 1Ѵ|u; Ő)$ő
were examined using confocal laser scanning microscopy (CLSM). 
There was a significant decrease in the nuclear localization with a 
concomitant increase in the cytoplasmic labeling for all the analyzed 
proteins in both HGPS cell cultures, with the exception of HDAC1 
that was found to be mislocalized only in HGPS-2 cells (Figure 1a 
and Figure S1). Quantitative analysis of the fluorescence nuclear/cy-
toplasmic ratio (Fn/c) corroborated these observations (see graphs). 
Nuclear accumulation of NES-containing proteins was restored to 
- vblbѴ-u Ѵ;;Ѵ |o |_-| o=)$ 1;ѴѴv rom |u;-|l;m| o= " 1;ѴѴv
for 1 day with 1 nM leptomycin B (LMB), a specific CRM1 inhibitor 
(Figure 1a and Figure S1). This clearly indicates that their nuclear 
depletion is caused by enhanced nuclear export activity rather than 
nuclear import failure. Next, we analyzed the expression of NES-
containing proteins in HGPS cells. The levels of STAT3 and B23 were 
vblbѴ-u0;|;;m)$-m7"1;ѴѴvķ_bѴ;-m-rr-u;m|bm1u;-v;=ou
ZO-2 was observed only in HGPS-2 fibroblasts (Figure 1b).
ƑĺƑՊ|Պm_-m1;7m1Ѵ;-uruo|;bm;rou|bm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is caused by progerin-induced CRM1 overexpression
); _ro|_;vb;7 |_-| |_; ;-1;u0-|;7 m1Ѵ;-u ;rou| -1|bb|
of HGPS cells might be consequence of CRM1 overexpression. 
Consistent with this idea, elevated CRM1 protein levels were found 
in HGPS cells (Figure 1c,d), with qRT-PCR experiments showing a 
corresponding increase in CRM1 mRNA levels (Figure 1e). Given that 
CRM1 overexpression is primarily regulated at the transcriptional 
level, we next analyzed CRM1 promoter activity in HGPS cells by 
promoter reporter assays. An increase in CRM1 promoter activity 
-v=om7bm"ŊƑ0|mo|"ŊƐ1;ѴѴvķ1olr-u;7b|_)$1;ѴѴv
(Figure 1f).
  + )  ! 	 "
aging, cellular senescence, exportin CRM1, Hutchinson-Gilford progeria syndrome, lamin B1, 
progerin
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and HGPS cells, treated for 24 hr with 10 nM LMB or vehicle alone, were immunolabeled for the indicated proteins (bar, 10 µm). The Fn/c 
ratio was calculated (nƷƔƏ1;ѴѴvőķ-m7vb]mb=b1-m|7b==;u;m1;v;u;7;|;ulbm;70-mmŋ)_b|m;&|;v|Ő]u-r_vőĺŐ0őuo|;bmѴ;;Ѵvo=
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HGPS cells were immunolabeled for CRM1 and analyzed by CLSM. Typical images from 3 independent assays are shown (bar 10 µm). (d) 
v-|;v=uol)$-m7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relative CRM1 levels were obtained (graph). (e) CRM1 messenger RNA expression was examined by qRT-PCR. (d-e) Significant differences 
were determined by unpaired t |;v|ĺŐ=ő)$-m7"1;ѴѴv;u;|u-mv=;1|;7b|_0o|_1b=;u-v;u;rou|;u1omv|u1|1om|-bmbm]|_;
human CRM1 promoter and Renilla luciferase vector, which was used to normalize transfection efficiency. Enzymatic activities were 
estimated after incubation for 48 hr as described in Methods. Data represent mean ± SEM of three independent experiments (unpaired 
t|;v|őĺŐ]őv-|;v=uol;-1;ѴѴvv|-0Ѵ|u-mv=;1|;7|o;ru;vvŊѴ-lbmouŊruo];ubm;u;v0f;1|;7|o);v|;um0Ѵo||bm]vbm]
antibodies against CRM1, GFP, or actin (loading control). (h) HeLa cells expressing GFP-lamin A or GFP-progerin were subjected to 
chromatin immunoprecipitation (ChIP) with anti-NF-YA antibodies followed by PCR for the CRM1 promoter region. Data correspond to 
two independent experiments in triplicate
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To ascertain whether CRM1 overexpression is causally linked 
to progerin, we evaluated whether exogenous expression of pro-
gerin is sufficient to elicit increased CRM1 levels in HeLa cells. 
Expression of GFP-progerin but not GFP-lamin A resulted in nu-
clear morphology aberrations (Figure S2a), decreased H3K9m3 
levels (Figure S2b), and increased CRM1 levels (Figure 1g); the lat-
ter appears to provoke in turn cytoplasmic mislocalization of the 
"Ŋ1om|-bmbm] "$$ƒ Őb]u; "Ƒ1őĺ); |_;m ;-Ѵ-|;7_;|_;u
exogenously expressed progerin induces CRM1 promoter activ-
ity, using ChIP-qPCR assays to assess binding activity of NF-YA, a 
transcription factor that positively regulates the CRM1 promoter 
Ő-m7;u)-||ş ;-m;uķ ƑƏƐƐőĺ $_;0bm7bm] -1|bb| o=Ŋ+ |o
the CRM1 promoter region was found to be augmented by ~30% 
in GFP-progerin-expressing cells, compared with those expressing 
GFP-lamin A (Figure 1h).
Because progerin toxicity is attributed at least in part to 
its farnesyl moiety, we next examined whether inhibition of progerin 
farnesylation using the farnesyltransferase inhibitor (FTI) lonafarnib 
would reduce overexpression of CRM1 in HGPS cells. As previously 
reported (Noda et al., 2015), treatment with 25 µM of lonafarnib 
for 3 days elicited a significant decrease in both nuclear blebbing 
(Figure S3a) and progerin levels (Figure S3b). Supporting our idea, 
the decrease in progerin levels resulted in CRM1 downregulation 
(Figure S3b).
ƑĺƒՊ|Պ_-ul-1oѴo]b1-Ѵ-||;m-|bomo=!Ɛ-1|bb|
rescues premature senescence in HGPS cells by 
improving lamin B1 levels
);om7;u;7_;|_;u;m_-m1;7!Ɛ-1|bb|lb]_|0;r-u|o=
the molecular basis underlying HGPS. To address this, we evalu-
ated whether amelioration of CRM1 activity through LMB treat-
ment has an impact on cellular senescence. Remarkably, LMB 
treatment for 2 days resulted in a significant reduction of senes-
cence cells in HGPS cultures, as determined by senescence-asso-
ciated β-galactosidase (SA-β-gal) staining (Figure 2a). Consistent 
with this, the percentage of HGPS-1 and HGPS-2 cells arrested 
at G0/G1 phase of the cell cycle decreased upon treatment with 
ķ-vu;;-Ѵ;70=Ѵo1|ol;|u-m-ѴvbvŐb]u;"Ɠ-őĺ);m;|
analyzed the effect of LMB on cell proliferation. Treatment with 
LMB for 3 days resulted in significantly decreased cell growth in 
0o|_)$-m7"1;ѴѴvĸ_o;;uķ b|ruooh;7omѴ- vѴb]_| bm-
crease in cell death by the third day, as shown by MTT and an-
nexin V assays (Figure S4b,c, respectively). Since decreased lamin 
B1 expression is associated with senescence (Freund, Laberge, 
	;l-ub-ķş-lrbvbķƑƏƐƑĸ"_blb;|-ѴĺķƑƏƐƐőķ;;u;ruolr|;7
to analyze whether treatment with LMB has a positive effect on 
lamin B1 levels. A ~80% decrease in lamin B1 levels was observed 
in HGPS cells incubated with vehicle alone. Nevertheless, par-
tial restitution of lamin B1 expression was obtained after incu-
bation of HGPS fibroblasts with LMB (50 nM) for 6 days, while 
mo1_-m];v;u; =om7 bm)$1;ѴѴvrom |u;-|l;m| Őb]u;Ƒ0őĺ
Redistribution of lamin B1 into distinct nucleoplasmic foci was 
observed in LMB-treated HGPS cells (Figure 2c). It is thought that 
nucleoplasmic foci of lamin B1 correspond to nascent lamin B1 
incorporated in the nucleoplasmic reticulum in interphase nuclei 
Ő	uo7ķb-m]ķ|ovhbķuo;mouķş(-ķƑƏƐƕőĺ
);1omvb7;u;7|_-|u;v|ou-|bomo=Ѵ-lbmƐѴ;;Ѵvlb]_|1omv;-
quently reduce those HGPS characteristics governed by lamin B1 
Ő-lrv;|-ѴĺķƑƏƐƓőĺ); |_;m;-lbm;7 |_; blr-1|o=|u;-|-
ment on heterochromatin organization using the heterochromatin 
marker H3K9me3. Supporting our idea, recovery of both nuclear 
staining and protein levels of H3K9me3 was evidenced in HGPS cells 
after LMB treatment (Figure 2d,e, respectively).
);m;|;-lbm;7|_;;==;1|o=omm1Ѵ;-ulour_oѴo]ķ
using nuclear morphometric analyses. Nuclear defects were com-
monly found in vehicle-treated HGPS fibroblasts immunostained 
=ou Ѵ-lbm ņķ 1olr-u;7 b|_)$ 1;ѴѴv Őb]u; ƒ- -m7 ]u-r_vőĺ
Remarkably, ovoid-shaped nuclei devoid of irregularities that re-
v;l0Ѵ;)$m1Ѵ;b;u;;b7;m|-=|;u|u;-|l;m|o="1;ѴѴv=ou
3 days with LMB (Figure 3a). Nuclear morphometric analyses con-
firmed significant differences between vehicle- and LMB-treated 
HGPS cells (right graphs). Collectively, these data indicate that 
mitigation of CRM1 activity through LMB treatment delayed the 
progression of HGPS cells to senescence by preventing lamin B1 
downregulation.
ƑĺƓՊ|Պ_-ul-1oѴo]b1-Ѵlo7Ѵ-|bomo=!Ɛ-1|bb|
ameliorates aging features of HGPS cells
To analyze in depth the effect of LMB-mediated CRM1 inhibition 
on senescence, two distinctive features of senescent cells, namely 
enlarged nucleolar morphology and senescent cellular morphol-
ogy, were examined in HGPS fibroblasts. As reported previously, 
Ő1_-Ѵ|;uş;|;uķƑƏƐƕőķ - vbm]Ѵ;ou |oruolbm;m|m1Ѵ;oѴb
with increased nucleolar area were observed in most HGPS cells 
(Figure 3b). Notably, administration of LMB to HGPS cultures for 
3 days resulted in increased number of nucleoli per cell (Figure 3b), 
with smaller nucleolar area (right graphs), which were comparable 
in size to wild-type nucleoli. Previously, the expansion of nucleoli 
was linked to elevated protein synthesis in HGPS cells (Buchwalter 
ş;|;uķƑƏƐƕőĺ$_;u;=ou;ķ;;u;ruolr|;7|o-m-Ѵ;_;|_;u
alleviation of nucleolar expansion by LMB treatment has an ef-
fect on global protein synthesis by monitoring the phosphoryla-
tion state of the α subunit of eukaryotic initiation factor 2 (eIF2α), 
the p70 ribosomal protein S6 kinase (p70 S6K) and its substrate, 
and the ribosomal protein S6 (rpS6). Consistent with elevated pro-
tein synthesis, HGPS-1 cells treated with vehicle alone showed 
decreased p-eIF2a levels but elevated levels of p-p70 S6K and p-
rpS6K (Figure 3c). By contrast, LMB treatment for 3 and 6 days 
resulted in increased p-eIF2α levels but reduced phosphorylated 
levels of both p70 S6K and rpS6 in HGPS-1 cells (Figure 3c), which is 
consistent with a translational repression effect mediated by LMB. 
)b|_ u;vr;1| |o |_; v;m;v1;m| 1;ѴѴ lour_oѴo]ķ Ŋl;7b-|;7
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inhibition of CRM1 activity shifted the flattened and expanded 
morphology of HGPS fibroblasts to the typical fusiform morphol-
o]o=)$=b0uo0Ѵ-v|vŐb]u;ƒ7őķb|_-1om1olb|-m|7;1u;-v;bm
cell size (right graph).
Finally, we assessed whether treatment with LMB has an effect 
on progerin expression. Interestingly, progerin levels were found to 
significantly decrease in HGPS-2 cells but not HGPS-1 cells upon 
LMB treatment (Figure S4c).
   & !   Ƒ ՊŊl;7b-|;7bm_b0b|bomo=!Ɛru;;m|v1;ѴѴѴ-uv;m;v1;m1;0blruobm]Ѵ-lbmƐѴ;;ѴvĺŐ-ő)$-m7"=b0uo0Ѵ-v|v
were treated for 2 days with 1 nM LMB or vehicle alone. The activity of β-galactosidase was assessed, and representative images are 
shown. Bar = 100 µM. The percentage of senescent cells was calculated from 3 separate experiments (n = 300 cells for each condition). 
Ő0őv-|;v=uol)$-m7"=b0uo0Ѵ-v|vķru;bovѴ|u;-|;7=ouѵ7-vb|_ƔƏmou;_b1Ѵ;ķ;u;-m-Ѵ;70);v|;um0Ѵo||bm]
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HGPS fibroblasts treated with 50 nM LMB or vehicle for 6 days were analyzed by CLSM, using antibodies against H3K9me3 and lamin A/C. 
Representative images are shown. B Bar, 10 µm. Bottom. Line profile analysis showing H3K9me3 fluorescence pattern. (e) Lysates from 
"1;ѴѴv|u;-|;7-vr;;u;u;-m-Ѵ;70);v|;um0Ѵo||bm]vbm]-m|b0o7b;v-]-bmv|ƒƖl;ƒ-m7-1|bmŐ1om|uoѴőĺ!;Ѵ-|b;ƒƖl;ƒ
levels are shown (right graph). (b and e) Significant differences were determined by unpaired t test
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3 days with 50 nM LMB or vehicle alone. Cells were immunolabeled for lamin A/C before being analyzed by CLSM, and representative 
images are shown. Bar, 10 µm. Right. Nuclear morphometric analysis was carried out as described in Methods (n = 200 nuclei for each 
1om7b|bomőķb|_vb]mb=b1-m|7b==;u;m1;v7;|;ulbm;70-mmŋ)_b|m;&|;v|ĺŐ0ő)$-m7"=b0uo0Ѵ-v|vķ|u;-|;7-vr;;uķ;u;
immunostained for fibrillarin to decorate nucleoli. Bar, 10 µm. Right. Nucleolar area was determined as described in Methods (n > 600 
nucleoli per condition). Number of nucleoli per cell was estimated (bottom panel; n > 80 cells per sample), and significant differences were 
7;|;ulbm;70-mmŋ)_b|m;&|;v|ĺŐ1őv-|;v=uol)$-m7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experiments are shown (bottom graphs), with significant differences determined by unpaired t |;v|ĺŐ7ő)$-m7"=b0uo0Ѵ-v|v;u;
treated as peer A. Cells were labeled with phalloidin to visualize actin cytoskeleton. Bar, 50 µM. Right. The cellular area was estimated 
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   & !   Ɠ Պ Ectopic overexpression of CRM1 induces premature aging phenotype in normal primary fibroblasts. Human primary 
fibroblasts derived from a healthy donor were stably transfected to express Flag-CRM1 or Flag alone. (a) Lysates were subjected to 
);v|;um0Ѵo||bm]vbm]-m|b0o7b;v-]-bmv|!Ɛķ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distribution of STAT3 was evaluated by CLSM and its n/c ratio estimated (graph). Bar, 10 µM. (c) The activity of β-galactosidase was 
measured, and the percentage of senescent cells was estimated from 3 independent experiments (n = 300 cells for condition). Bar, 100 µM. 
(a-c) Significant differences were determined by unpaired t test. (d) Transfected fibroblasts were labeled with phalloidin to visualize actin. 
Right. Flag-CRM1-expressing fibroblasts were treated with 50 nM LMB or vehicle alone for 3 days, prior to being stained with phalloidin and 
analyzed by CLSM. Bar, 50 µM. The cellular area was determined (n > 150 cells for condition), and significant differences were determined 
0-mmŋ)_b|m;&|;v|ĺŐ;őv-|;v=uol=b0uo0Ѵ-v|v;ru;vvbm]Ѵ-]ouѴ-]Ŋ!Ɛķ_b1_;u;ru;bovѴ|u;-|;7b|_ƔƏmou
;_b1Ѵ;-Ѵom;=ouvb7-vķ;u;-m-Ѵ;70);v|;um0Ѵo||bm]b|_-m|b0o7b;v-]-bmv|Ѵ-lbmƐ-m7-1|bmŐ1om|uoѴőĺBottom. Relative lamin B1 
levels are shown. Significant differences were determined by unpaired t test. (f) Transfected fibroblasts with or without LMB treatment were 
immunostained for lamin B1, and typical images are shown. Bar, 10 µm. Bottom. Line profile analysis showing lamin B1 fluorescence pattern. 
Ő]ő)$=b0uo0Ѵ-v|vv|-0Ѵ;ru;vvbm]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Bottom. Relative H3K9me3 levels are shown, and significant differences were determined by unpaired t test. (h) Nuclear distribution of 
H3K9me3 was analyzed in the indicated transfected fibroblasts with or without LMB treatment. Bottom. Line profile analysis showing the 
H3K9me3 fluorescence pattern
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HGPS phenotype in normal human fibroblasts
Next, we ascertained whether exogenous overexpression of CRM1 
is sufficient to mimic progeroid hallmarks in normal fibroblasts. A 
~100% increase in CRM1 levels was observed after stable transfec-
|bomo=)$=b0uo0Ѵ-v|vb|_-;1|ou;ru;vvbm]Ŋ!Ɛķ1ol-
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mislocalization of the NES-containing protein STAT3 confirmed 
accelerated nuclear export activity in cells overexpressing CRM1 
   & !   Ɣ Պ (a-b) Enhanced nuclear export activity due to CRM1 overexpression overcomes deficient Ran gradient in HeLa cells. Cells 
were double-transfected to stably expressed Flag-CRM1 or Flag alone, and a shRNA against NTF2 gene or a shRNA control. (a) Lysates from 
|_;|u-mv=;1|;71;ѴѴv;u;-m-Ѵ;70);v|;um0Ѵo||bm]vbm]-m|b0o7b;v-]-bmv|!Ɛķ$Ƒķ-m7-1|bmŐ1om|uoѴőĺMiddle. Relative protein 
levels were assessed from three independent experiments (unpaired t test). Right. Distribution of STAT3 was analyzed in the indicated 
|u-mv=;1|;71;ѴѴvĺ-uķƑƏ੿ĺŐ0ő$u-mv=;1|;71;ѴѴѴv-|;v;u;-m-Ѵ;70);v|;um0Ѵo||bm]b|_-m|b0o7b;v-]-bmv|Ѵ-lbmƐķƒƖl;ķ-m7
actin (control). Middle. Data correspond to 3 independent experiments (unpaired t test). Right. Distribution of H3K9me3 was analyzed in the 
indicated transfected cells. Bar, 20 µM. (ce) Restoration of lamin B1 expression in HGPS cells (c) HGPS-1 cells were transiently transfected 
to express GFP-lamin B1 or GFP alone. Transfected cells were immunolabeled for lamin A/C (d) and H3K9m3 (e) to estimate the percentage 
of cells with aberrant nuclear morphology and heterochromatin loss, respectively. Bar, 10 µM
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blasts became senescent (75%), as shown by SA-β-gal staining and 
the acquisition of a flattened and extended cellular morphology 
(Figure 4c,d, respectively). Furthermore, forced overexpression 
o= !Ɛ bm)$ =b0uo0Ѵ-v|v u;vѴ|;7 bm 7;1u;-v;7 Ѵ-lbm Ɛ Ѵ;;Ѵv
(Figure 4ef), with the consequent loss of H3k9m3 (Figure 4gh). 
Interestingly, pharmacological inhibition of CRM1 in FLAG-CRM1-ex-
pressing fibroblasts alleviated the senescent morphology (Figure 4d) 
and prevented both lamin B1 downregulation (Figure 4e,f) and the 
loss of heterochromatin (Figure 4g,h).
The gradient of Ran, a key regulator of nucleocytoplasmic trans-
port, was previously reported as disrupted in HGPS cells (Datta, 
"moķ ş -v1_-Ѵķ ƑƏƐƓőĺ ); |_;u;=ou; bm;v|b]-|;7 _;|_;u ;m-
hanced nuclear export activity via CRM1 overexpression can occur 
in cells with a deficient Ran gradient. Since depletion of the Ran im-
port factor NTF2 (nuclear transport factor 2) is sufficient to disrupt 
the Ran gradient (Datta et al., 2014; Dworak et al., 2019), HeLa cells 
were double-transfected to express CRM1 and a shRNA against 
NTF2. Interestingly, stably transfected HeLa cells having both over-
expressed levels of CRM1 and depleted levels of NTF2 (Figure 5a) still 
   & !   ѵ Պ CRM1 expression and activity increased during normal aging. (a) Primary human fibroblast from healthy individuals of varying 
-];vou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expression is shown (bottom panel; unpaired t test). (b) Localization of the NES-containing proteins STAT3, Z0-2, and B23 was evaluated 
in the indicated fibroblast cultures, treated with LMB or vehicle alone for 24 hr. Typical images are shown. Bar, 20 µM. (c) The n/c ratio of 
STAT3, Z0-2, and B23 was calculated as peer Methods (nƷƔƏ1;ѴѴvĸ-mmŋ)_b|m;&|;v|ő
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showed elevated nuclear export activity, as shown by cytoplasmic 
mislocalization of the NES-containing protein STAT3 (right panel). 
Consequently, these cells acquired different aging marks, including 
depleted levels of lamin B1 and H3K9m3 (Figure 5b). Collectively, 
these data imply that enhancing CRM1 activity is necessary and suf-
ficient to induce the cells to age prematurely.
ƑĺѵՊ|Պ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partially alleviates the HGPS phenotype
To ascertain whether improvement of lamin B1 levels by LMB treat-
ment is the basis of the HGPS phenotype rescue, the expression of 
lamin B1 was exogenously restored in HGPS-1 cells by stably trans-
fecting a vector expressing GFP-lamin B1. GFP-lamin B1 was prop-
erly targeted to the nuclear envelope, while GFP alone was localized 
throughout all the cells (Figure 5c). Remarkably, HGPS cells express-
ing GFP-lamin B1 showed improved nuclear morphology (Figure 5d) 
and recovery of peripheral heterochromatin (Figure 5e), compared 
with HGPS-1 cells expressing GFP alone. However, restoration of 
lamin B1 expression failed to alleviate the senescent morphology 
(data not shown).
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during normal aging
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could be dysregulated during normal aging as well. Thus, we ana-
lyzed expression and activity of CRM1 in a panel of primary human 
fibroblasts from healthy individuals ranging from 10 to 91 years 
of age. Interestingly, we found a significant and direct correlation 
between aging and increased CRM1 levels in individuals between 
38 and 91 years of age (Figure 6a). Cytoplasmic mislocalization of 
the NES-containing proteins STAT3, Z0-2, and B23 was evident 
in fibroblasts from 74- to 91-year-old individuals (Figure 6b), with 
Fn/C analysis corroborating these observations (Figure 6c); further 
treatment with LMB restored predominant nuclear localization of 
NES-containing proteins, similar to that observed in fibroblasts 
from 10- to 38-year-old individuals (Figure 6b-c). Altogether, these 
data suggest that enhanced CRM1 activity is a hallmark of physi-
ological aging.
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In this study, we show for the first time that the CRM1-driven nu-
clear protein export mechanism is abnormally enhanced in HGPS 
1;ѴѴv 7; |oo;u;ru;vvbomo=!Ɛĺ); u;;-Ѵ;7 |_-|ru;]-
lation of CRM1 in HGPS cells is controlled at the transcriptional 
level through induction of CRM1 promoter activity, at least for 
HGPS-2 cells. Furthermore, a causal link between progerin and 
CRM1 overexpression was demonstrated because ectopic ex-
pression of progerin in HeLa cells elicited elevated CRM1 levels, 
at least in part through enhancing the binding activity of NF-YA 
(a positive transcription factor) to the CRM1 promoter region, 
and because treatment of HGPS cells with FTI that decreased 
ruo];ubm Ѵ;;Ѵv u;vѴ|;7 bm |um bm 7omu;]Ѵ-|bomo=!Ɛĺ);
speculated that exacerbated nuclear export activity might be part 
of the molecular basis underlying HGPS. As proof of concept, we 
evaluated whether inhibition of CRM1 activity by pharmacological 
treatment with LMB has a therapeutic effect on the HGPS phe-
notype. Remarkably, we found alleviation of virtually all HGPS 
hallmarks upon treatment with LMB, including reduced number 
of SA-β-gal positive cells, recovery of peripheral heterochromatin, 
and rescue of lamin B1 downregulation, nucleolar expansion, aug-
mented protein synthesis, and the senescent cellular morphology. 
Furthermore, ectopic overexpression of CRM1 enabled normal 
fibroblasts to acquire all the aging marks aforementioned. Thus, 
CRM1 overexpression is sufficient to recapitulate an aging phe-
notype in the absence of progerin, which indicates that a dysregu-
lated nuclear protein export is an early key event in the pathway 
leading to HGPS.
Most of the cellular processes rescued by LMB treatment are in-
timately related to lamin B1, including nuclear morphology (Vergnes, 
;|;u=ķ ;u]oķ +om]ķ ş !;;ķ ƑƏƏƓőķ ou]-mb-|bom o= r;ubr_;u-Ѵ
heterochromatin, nucleolar plasticity (Camps et al., 2014), and cellu-
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Therefore, it is likely that rescue of the HGPS phenotype by treat-
ment with LMB relies mainly on the improvement of lamin B1 levels. 
Consistent with this, exogenous expression of lamin B1 resulted in 
improved nuclear morphology and the recovery of peripheral het-
erochromatin, but failed to alleviate the senescent morphology of 
HGPS cells. Thus, alleviation of the HGPS aging marks appears to 
occur through more than one mechanism; further experiments are 
required to fully delineate pathways underlying the correction of 
aging marks in response to CRM1 inhibition.
A broad spectrum of treatments against HGPS has been tested 
in HGPS fibroblasts (Harhouri et al., 2018), and most of these are 
designed to target progerin. Blocking of progerin farnesylation 
by administration of farnesyltransferase inhibitors corrected nu-
clear structure but failed to alleviate other aging-associated marks 
ŐѴmmşѴo;uķƑƏƏƔĸ$o|_;|-ѴĺķƑƏƏƔő, while depletion of proge-
ria via rapamycin-mediated activation of autop hagy improved nu-
clear morphology and delayed the onset of senescence (Cao et al., 
2011). In a similar manner, proteasome inhibitor MG132 enhanced 
proliferation and decreased cellular senescence by promoting 
progerin degradation (Harhouri et al., 2017). Finally, treatment 
b|_|_;1_;lb1-ѴƓ-l;Ѵbou-|;7m1Ѵ;-u7;=;1|v-m7ru;;m|;7
premature senescence by interfering with the harmful interac-
tion between progerin and lamin A (Lee et al., 2016). Alternative 
strategies aimed to repair downstream effects of progerin have 
been proposed as well; treatment with methylene blue rescued 
not only nuclear morphology and heterochromatin loss but also 
mitochondrial function (Xiong et al., 2016), while administration 
of the ROCK inhibitor Y-27632 ameliorated nuclear morphology 
defects and DNA double-strand breaks along with decreased ROS 
ՊՍՊ |ՊƐƐo=ƐƓGARCÍA-AGUIRRE ET AL.
levels and improvement of mitochondrial function (Kang et al., 
2017). In this scenario, pharmacological modulation of CRM1 using 
selective inhibitors clearly provides a viable and promising ther-
apy against HGPS, because this treatment specifically targets and 
corrects the nuclear export mechanism and, more importantly, 
because it alleviates the largest number of HGPS cellular charac-
teristics (Graphical abstract), compared with the aforementioned 
treatments. Furthermore, synthetic selective inhibitors of CRM1 
with pharmacological properties superior to LMB (selinexor/
KPT-330), which have shown to be well-tolerated in human cancer 
1Ѵbmb1-Ѵ |ub-Ѵv Ő-_br-Ѵş-Ѵ-=-ķƑƏƐѵőķoѴ7 =-1bѴb|-|; =|u; bm
vivo evaluation of this therapy in HGPS animal models.
Interestingly, we found increased CRM1 levels in primary fibroblast 
from healthy aged donors; however, no progerin was detected in these 
cell cultures. In analogy to the mechanism underlying CRM1 overex-
ru;vvbom bm1-m1;u1;ѴѴv Ő-m7;u)-||ş;-m;uķƑƏƐƐőķ;_ro|_;-
sized that upregulation of CRM1 in fibroblasts from aged individuals 
could be controlled by modulation of the binding activity of transcrip-
tion factors involved in CRM1 promoter activity. Thus, enhanced 
CRM1-mediated nuclear export activity appears to be a key converg-
ing mechanism in both pathological and physiological aging. Consistent 
with this notion, silencing or pharmacological inhibition of CRM1 re-
sulted in extended lifespan in C. elegans (Silvestrini et al., 2018).
In conclusion, we reveal that enhanced nuclear protein export 
is a new hallmark of both HGPS and normal aging. Furthermore, we 
provide evidence that pharmacological inhibition of CRM1 activity 
alleviates the progeroid cellular phenotype (Graphical abstract), 
which delineates CRM1 as potential therapeutic target for HGPS 
and other aging-related diseases.
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Primary human dermal fibroblasts from patients with HGPS and 
healthy donors (see Table 1) were cultured in MEM (Invitrogen) sup-
plemented with 15% FBS (Invitrogen), nonessential amino acids, and 
antibiotics. All experiments were carried out with fibroblast cul-
|u;v-|r-vv-];ml0;uvƐƑŋƐѵĺ)_;u;bm7b1-|;7ķ=b0uo0Ѵ-v|v;u;
treated with 1 nM leptomycin B (LMB; Sigma-Aldrich) for 1, 3, or 
6 days diluted in ethanol to a final concentration of 0.1% in the cul-
ture medium, or with 25 µM of the farnesyl transferase inhibitor (FTI) 
lonafarnib (Sigma-Aldrich) for three days. Fibroblasts were trans-
fected with Lipofe ctamine 3,000 following manufacturer's protocol 
(Invitrogen). Stably transfected fibroblasts were obtained by cultur-
ing them for 12 days with 200 μg/ml G418 (Invitrogen). HeLa cells 
were double-transfected with pFlag-CRM1 vector and vector ex-
pressing either a short hairpin RNA (shRNA) specific for the human 
nuclear transport factor 2 gene (NUTF2) or a scrambled shRNA 
control (GeneCopoeia, Inc.), using Lipofe ctamine 2000 (Invitrogen). 
Stably transfected HeLa cells were obtained by culturing them for 
6 days in the presence of 1 μg/ml puromycin and 800 μg/ml G418. 
Cloning strategies to obtain vectors pEGFP-C1-LB1, pFLAG-CRM1, 
and pCRM1 promoter are provided under request.
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with both the CRM1 promoter vector, which expresses Firefly lucif-
erase under the control of human CRM1 promoter, and the Renilla 
luciferase vector as a control to normalize for differences in trans-
fection efficiency. After 48 hr, the luciferase activity was measured 
using Dual Luciferase Assay kit (Promega).
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Q-ChIP assays were performed as reported previously (Morales-
Lazaro et al., 2010), using 7.8 µg of mouse anti-NF-YA antibodies or 
7.8 µg of mouse IgG (irrelevant control). 20 ng of DNA was used to per-
form quantitative PCR (qPCR) using SYBR Green and primers specific 
|o-lrѴb=|_;!Ɛruolo|;uu;]bomŐ-m7;u)-||ş;-m;uķƑƏƐƐőĺ
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microscopy analysis
Immunostaining and CLSM analyses were carried out following 
standard techniques, using the appropriate primary antibodies 
(Table 2) and the corresponding secondary fluorochrome-con-
f]-|;7 -m|b0o7b;v Ő-1hvom llmo!;v;-u1_ -0ou-|oub;vőĺ
Images were acquired with the confocal laser system TCS-SP5, 
Leica. Quantification of nucleus/cytoplasm fluorescence inten-
sity was performed as reported previously (Aguilar et al., 2015). 
Morphometric analysis of nuclei was performed with software 
Culture Origin l|-|bom Age of donor at biopsy Gender
ƏѶƓѵƖŐ)$ő Coriell None 38 M
ƐƐƔƐƒŐ"ƴƐő Coriell G608G 8 F
ƐƐƓƖѶŐ"ƴƑő Coriell G608G 14 M
AG08470 Coriell None 10 F
AG06290 Coriell None 74 M
AG10884 Coriell None 87 M
AG07725 Coriell None 91 M
$     Ɛ Պ List of human dermal 
fibroblast cultures used in this study
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cross-sectional area occupied by a mark corresponding to fibril-
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ƓĺƔՊ|Պ";m;v1;m1;Ŋvvo1b-|;7β-Galactosidase (SA-β-
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Fibroblasts seeded on coverslips were stained with SA-β-Gal fol-
lowing manufacturer's instructions (Senescent Cell Histochemical 
Staining Kit, Sigma-Aldrich). Blue-stained cells expressing β-galactosi-
dase (senescent cells) were observed under bright-field microscopy.
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Immunoblotting analyses were carried out following standard protocol. 
Specific proteins were visualized using the Enhanced Chemiluminescence 
ŐŤő);v|;um0Ѵo||bm]7;|;1|bomvv|;lŐl;uv_-l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Healthcare), according to the manufacturer's instructions.
$     Ƒ Պ List of antibodies and plasmids used in this study
Antibodies
Antibody target Supplier Host
	bѴ|bom
WB IF
STAT3 "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴƓѶƑő Rabbit polyclonal 1:3,000 1:50
B23 "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴѵƏƐƒŊ-ő Rabbit polyclonal 1:3,000 1:50
Cyclin B1 "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴƕƔƑő Rabbit polyclonal N/A 1:100
GFP "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴѶƒƒƓő Rabbit polyclonal 1:1,500 N/A
CRM1 ovboѴo]b1-ѴvķŐ-|ĹƐƏƏƴƕƖѶƏƑő Rabbit polyclonal 1:4,000 1:250
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,ƴƑ Zymed Laboratories (Cat: 711400) Rabbit polyclonal 1:1,000 1:200
FLAG Cell Signaling Technology (Cat: 2368) Rabbit polyclonal 1:1,000 N/A
Dp71 Genemed Synthesis (Cat: +78Dp71) Rabbit polyclonal N/A 1:100
Lamin A/C "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴƑƏѵѶƐő Rabbit polyclonal 1:4,000 N/A
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HDAC "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴƕѶƕƑő Rabbit polyclonal N/A 1:60
NTF2 "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴѶƏƏƏѶő Mouse monoclonal 1:150 1:50
Phospho-p70 S6K Santa Cruz Biotechnology (Cat: Sc230) Rabbit polyclonal 1:300 N/A
Phospho-rpS6 Cell Signaling Technology (Cat: 4857) Rabbit monoclonal 1:1,000 N/A
Phospho-eIF2α Cell Signaling Technology (Cat: 9721) Rabbit polyclonal 1:1,000 N/A
Actin Dr. Manuel Hernández, CINVESTAV, Mexico Mouse monoclonal 1:3,000 N/A
NF-YA "-m|-ubo|;1_moѴo]Ő-|Ĺv1ƴƐƕƕƔƒ*ő Mouse monoclonal N/A N/A
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-l; Supplier
pBABE-puro-GFP-wt-lamin A Addgene
pBABE-puro-GFP-progerin Addgene
pFLAG-hCRM1 Addgene
rƒŊ(ƴƐƏ Addgene
Flag-CRM1 This study
pSG5-LB1 MSc Paulina Azuara, CINVESTAV, Mexico
pEGFP-C1 Addgene
pEGFP-C1-LB1 This study
CSHCTR001-nH1 GeneCopoeia
"Ŋ"ƏƖƏƑƏƖŊmƐƴƏƐ- GeneCopoeia
pCRM1promoter This study
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The analysis of cell cycle was carried out on a BD LSRFortessa flow 
cytometer (BD Biosciences), using the ModFit LT software (Verity 
Software House). Cell proliferation was assessed by the 3-(4,5-di-
methylthiazole-25-diphenyl tetrazolium bromide (MTT) assay, as 
reported previously (Velez-Aguilera et al., 2018).
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Total RNA was isolated from fibroblasts using the Direct-zolTM RNA 
MiniPrep Kit (Zymo Research), according to the manufacturer's in-
structions. RT-qPCR was carried on the StepOnePlus Real-Time PCR 
System (Applied Biosystems), using the KAPA SYBR Fast One-Step 
qRT-PCR system (Kapa Biosystems) and following a standard protocol. 
The expression levels for CRM1 mRNA were measured by the 2ΔΔct 
method and normalized to GAPDH mRNA values. Primer sequences 
for CRM1 and GAPDH amplification will be provided under request.
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Statistical analyses were performed by the two-tailed unpaired 
Student's t test. Data represent the mean ± SEM from a series of 
three separate experiments, and p values < 0.05 are indicative of sta-
|bv|b1-Ѵvb]mb=b1-m1;ĺ)_;u;bm7b1-|;7ķv|-|bv|b1-Ѵ-m-Ѵvbv-v1-uub;7
o|vbm];-1|momr-u-l;|ub1-mmŋ)_b|m;&|;v|oumr-bu;7t 
test and data were summarized by the mean ± SEM or the mean ± SD 
from a series of three separate experiments. p values < 0.05 were 
considered as significant. All statistical analyses were performed 
using GraphPad Prism 5 software (San Diego).
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